Skip to content
VedaBio logo

VedaBio

VedaBio is a YC Summer 2021 (S21) company. Based in San Diego, CA, USA; Urbana, IL, USA. Team of 30.

  • Hard Tech

About VedaBio

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

VedaBio builds CRISPR-based molecular diagnostic tests for urgent care, delivering syndromic respiratory panel results in under ten minutes at the point of care. The system pairs a benchtop instrument with a single-use cartridge and requires no laboratory or trained operator, running at the molecular accuracy level without target amplification. It replaces the current workflow where most urgent-care respiratory patients leave without a definitive diagnosis and are treated on incomplete information.

Go-to-market

Urgent care centers are the target customer, with a point-of-care instrument and cartridge designed to slot into existing clinic workflows without lab infrastructure or specialist training.

From the Y Combinator listing

How VedaBio describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

CRISPR powered Diagnostics with results in minutes.

Syndromic testing powered by engineered CRISPR enzymes. Get comprehensive results in every doctor visit. More at www.vedabio.com

Facts

Industry
Healthcare / Healthcare -> Diagnostics
Location
San Diego, CA, USA; Urbana, IL, USA
Team size
30
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works